{"id":1035057,"date":"2017-03-08T15:44:31","date_gmt":"2017-03-08T20:44:31","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/uncategorized\/study-gene-test-needed-before-using-alzheimers-drug-off-label-montana-standard.php"},"modified":"2024-08-17T15:42:35","modified_gmt":"2024-08-17T19:42:35","slug":"study-gene-test-needed-before-using-alzheimers-drug-off-label-montana-standard","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/gene-medicine\/study-gene-test-needed-before-using-alzheimers-drug-off-label-montana-standard.php","title":{"rendered":"Study: Gene Test Needed Before Using Alzheimer&#8217;s Drug &#8216;Off-Label&#8217; &#8211; Montana Standard"},"content":{"rendered":"<p><p> TUESDAY, March 7, 2017 (HealthDay News) -- A drug used to treat Alzheimer's disease should not be prescribed to people with milder mental impairment without first giving them a genetic test, a new study urges. <\/p>\n<p> The drug is donepezil (brand name: Aricept). <\/p>\n<p> Donepezil could speed mental decline in someone with mild cognitive impairment who has a specific genetic variation, according to Sophie Sokolow, an associate professor at the UCLA School of Nursing. <\/p>\n<p> She and her colleagues found that patients with the K-variant of the butyrylcholinesterase (BChE) gene who took donepezil deteriorated faster than those who took a placebo. <\/p>\n<p> Donepezil is approved in the United States to treat Alzheimer's disease but not mild cognitive impairment -- the stage between normal age-related decline and dementia. However, doctors often prescribe it \"off-label\" for patients with mild cognitive impairment, the study authors said. <\/p>\n<p> For this study, the researchers examined data from a U.S. government-funded study published in 2005 that assessed donepezil as a possible treatment for mild cognitive impairment. <\/p>\n<p> The findings reinforce the importance of physicians discussing the possible benefits and risks of donepezil with their patients, the researchers said in a university news release. <\/p>\n<p> The study was published recently in the Journal of Alzheimer's Disease. Funding was provide by the U.S. National Institute on Aging. <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>See the rest here:<br \/>\n<a target=\"_blank\" href=\"http:\/\/mtstandard.com\/lifestyles\/health-med-fit\/study-gene-test-needed-before-using-alzheimer-s-drug-off\/article_e091b022-4fbe-5bdf-ac53-0f029d70950a.html\" title=\"Study: Gene Test Needed Before Using Alzheimer's Drug 'Off-Label' - Montana Standard\" rel=\"noopener\">Study: Gene Test Needed Before Using Alzheimer's Drug 'Off-Label' - Montana Standard<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> TUESDAY, March 7, 2017 (HealthDay News) -- A drug used to treat Alzheimer's disease should not be prescribed to people with milder mental impairment without first giving them a genetic test, a new study urges. The drug is donepezil (brand name: Aricept). Donepezil could speed mental decline in someone with mild cognitive impairment who has a specific genetic variation, according to Sophie Sokolow, an associate professor at the UCLA School of Nursing.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/gene-medicine\/study-gene-test-needed-before-using-alzheimers-drug-off-label-montana-standard.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246858],"tags":[],"class_list":["post-1035057","post","type-post","status-publish","format-standard","hentry","category-gene-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1035057"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1035057"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1035057\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1035057"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1035057"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1035057"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}